Literature DB >> 1422375

Bovine insulin.

R Tattersall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1422375      PMCID： PMC1883490          DOI： 10.1136/bmj.305.6857.831

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Human insulin and hypoglycaemia: burning issue or hot air?

Authors:  G Williams; A W Patrick
Journal:  BMJ       Date:  1992-08-08

2.  Pharmacokinetics of human insulin zinc suspension (recombinant DNA) in normal man: a comparison with porcine insulin zinc suspension.

Authors:  B M Frier; F M Sullivan; F S Mair; I M Koch; J B Scotton
Journal:  Diabet Med       Date:  1984-09       Impact factor: 4.359

3.  Use of human ultralente as the basal insulin component in treatment of patients with IDDM.

Authors:  S L Freeman; P C O'Brien; R A Rizza
Journal:  Diabetes Res Clin Pract       Date:  1991-07       Impact factor: 5.602

4.  The subcutaneous absorption of human and bovine ultralente insulin formulations.

Authors:  P Hildebrandt; A Berger; A Vølund; C Kühl
Journal:  Diabet Med       Date:  1985-09       Impact factor: 4.359

5.  A practical guide to basal and prandial insulin therapy.

Authors:  R R Holman; R C Turner
Journal:  Diabet Med       Date:  1985-01       Impact factor: 4.359

6.  Brittle diabetes in the elderly.

Authors:  D N Griffith; J S Yudkin
Journal:  Diabet Med       Date:  1989-07       Impact factor: 4.359

7.  A strategy for selection of elderly type 2 diabetic patients for insulin therapy, and a comparison of two insulin preparations.

Authors:  H Tindall; H J Bodansky; M Stickland; J K Wales
Journal:  Diabet Med       Date:  1988-09       Impact factor: 4.359
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.